Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

HEALTHCARE (NY:XLV)

175.12 +5.39 (+3.17%)
Streaming Delayed Price Updated: 11:10 AM EDT, Aug 19, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about HEALTHCARE

< Previous 1 2 3 4 5 6 7 8 9
...
43 44 Next >
Janux Stock Is Rising Pre-Market After A New Oncology Deal With Bristol Myers Squibb ↗
Via Stocktwits
News headline image
Cathie Wood’s ARK Made Just One Buy Last Session — And It’s A Biotech Stock Up Nearly 30% YTD ↗
ARK doubles down on a CRISPR bet as Intellia Therapeutics’ stock heads for its best week since October. 
Via Stocktwits
Topics Artificial Intelligence ETFs
News headline image
Nano-Cap Regentis Biomaterials Stock Is Up Nearly 15% This Year: Why Retail Traders Are Swarming It ↗
Heading to close this week as its best week since IPO, RGNT has become a retail favorite with surging followers on Stocktwits. 
Via Stocktwits
Topics Initial Public Offering Intellectual Property
News headline image
MLTX Stock Erases Most Of 2025 Loses As Wall Street, Retail Bets On FDA Feedback For Sonelokimab ↗
The FDA said that the drug, which treats a chronic inflammatory skin disorder, could establish evidence without additional trials. 
Via Stocktwits
TG Therapeutics Stock Pops As Briumvi Boom Reignites Bull Case: Goldman Sachs Sees Room For 32% Rally ↗
Via Stocktwits
BDSX Stock Shot Up 23% Pre-Market Today — What’s Fueling The Surge? ↗
Via Stocktwits
Is Molina Healthcare The Next GEICO? Michael Burry Feels It's A ‘Special One’ ↗
Via Stocktwits
News headline image
Retail Traders Are Piling Into TG Therapeutics – What’s Driving The Chatter? ↗
On Tuesday, the company provided the revenue outlook for 2026 and fourth-quarter (Q4) and fiscal year 2025 revenue projection for BRIUMVI. 
Via Stocktwits
Topics Artificial Intelligence
News headline image
Ventyx’s $1.2B Buyout By Eli Lilly Proves Timing Often Beats Conviction In Biotech Investing — A VC Explains ↗
Bottom buyers saw over 2,000% gains, while IPO investors merely broke even after a 90% drawdown, according to Atlas Venture’s Bruce Booth. 
Via Stocktwits
Topics Initial Public Offering
News headline image
The Great Rebalancing: Why Healthcare is Leading the Market Charge in 2026
As the first week of 2026 draws to a close, a distinct shift in market leadership has become the defining story for Wall Street. After a multi-year period where technology and artificial intelligence... 
Via MarketMinute
Topics Artificial Intelligence Economy Government
News headline image
The Great Rebalancing: Tech Giants Retreat as Investors Pivot to Defensive Safety in 2025's Final Days
As the curtain closes on 2025, the "Great Rebalancing" has taken center stage in the financial markets. On this December 29, 2025, the dominant narrative that fueled triple-digit gains for AI-centric... 
Via MarketMinute
Topics Artificial Intelligence Economy World Trade
News headline image
Sector Rotation: 2 Smart Money Moves for 2026 ↗
Via MarketBeat
News headline image
Is Fidelity Medical Equipment the Ultimate "Forever Fund" for Health Care Investors? ↗
This basket of 64 medical device stocks could raise its dividend for decades. 
Via The Motley Fool
Topics ETFs Government Supply Chain
News headline image
S&P 500 Stumbles as Mixed Jobs Report Fuels Fed Speculation, Ford Axes F-150 Lightning in Major EV Pivot
The U.S. stock market experienced a notable downturn on Tuesday, December 16, 2025, with the S&P 500 leading the retreat, following the release of a November jobs report that presented a complex and... 
Via MarketMinute
Topics Economy Electric Vehicles Energy
News headline image
The Top 3 Investment Themes That Will Dominate 2026 ↗
Via MarketBeat
News headline image
5 Healthcare Names to Watch as Sector Rotation Is in Full Swing ↗
Via MarketBeat
News headline image
Tech Stocks Fall Despite Nvidia's Beat, Walmart Jumps 6%: What's Moving Markets Thursday? ↗
Nvidia Corp. (NASDAQ:NVDA) delivered another blockbuster quarter and raised its outlook, but even that wasn't enough to lift Wall Street on Thursday. 
Via Benzinga
News headline image
Interest Rate Hikes: A Looming Threat or Hidden Opportunity for the Stock Market?
As of mid-November 2025, the financial markets are grappling with a pervasive sense of uncertainty, primarily driven by the persistent specter of elevated interest rates. The "higher for longer"... 
Via MarketMinute
Topics Economy Stocks
News headline image
Tech Edges Up Ahead Of Nvidia's Earnings, Bitcoin Sinks Below $90,000: What's Moving Markets Wednesday? ↗
All eyes are on Nvidia Corp. (NASDAQ:NVDA) as the world's most valuable company prepares to report third-quarter earnings after the close, a pivotal moment that could steer 
Via Benzinga
News headline image
Leading And Lagging Sectors For November 19, 2025 ↗
 
Via Benzinga
News headline image
Bank of America Flashes "Sell Signal" as Investor Cash Dries Up, Raising Market Stability Concerns
Bank of America (NYSE: BAC) has recently sounded a significant alarm for the stock market, issuing a "sell signal" that has sent ripples of concern through the financial world. This cautionary... 
Via MarketMinute
Topics Artificial Intelligence Bonds Economy
News headline image
Tech Stocks Drop, Pharma Gains As Sector Rotation Picks Up: What's Moving Markets Tuesday? ↗
Wall Street endured another wave of selling in tech stocks on Tuesday, with the Nasdaq 100 down more than 1% by midday in New York, extending its month-to-date slide to more than 5%. 
Via Benzinga
News headline image
Leading And Lagging Sectors For November 18, 2025 ↗
 
Via Benzinga
News headline image
Is AI The Key To Beating Cancer? Why Pharma Stocks Are Soaring ↗
AI breakthroughs in pharma are pushing Eli Lilly and healthcare stocks higher—and may soon reshape how we fight cancer. 
Via Benzinga
Topics Artificial Intelligence
News headline image
Hedge Funds Snap Up Eli Lilly, United Healthcare, And More, Putting Healthcare ETFs Back In The Spotlight ↗
With funds buying Eli Lilly, UNH, and other pharma giants, healthcare ETFs can emerge as key beneficiaries of a broader defensive rotation. 
Via Benzinga
Topics ETFs
News headline image
Alphabet Rallies To Record Highs, Bitcoin Falters At $94,000: What's Moving Markets Monday? ↗
Wall Street kicked off the new week on a flat note after the worst weekly slump for tech stocks since April, as investors remained cautious ahead of a flood of economic data following the end of the... 
Via Benzinga
News headline image
Leading And Lagging Sectors For November 17, 2025 ↗
 
Via Benzinga
News headline image
This Sector Is Suddenly Crushing the Broader Market. Should You Invest $1,000? ↗
Healthcare stocks have far outperformed the broader market over the past month. 
Via The Motley Fool
Topics ETFs Government World Trade
News headline image
Eli Lilly Supremacy: How One Stock Is Dictating Performance Across Pharma ETFs ↗
A look into how Eli Lilly's growth and large weightings are influencing major pharma ETFs, leaving investors more exposed to one stock than they realize. 
Via Benzinga
Topics ETFs
News headline image
Fear Of An AI Bubble? This Sector Is Quietly Surging While Tech Sinks ↗
While AI stocks slide, healthcare is soaring. XLV leads November gains, outperforming tech as investors rotate. 
Via Benzinga
Topics Artificial Intelligence
< Previous 1 2 3 4 5 6 7 8 9
...
43 44 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.